{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "59676-800",
      "generic_name": "Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide",
      "labeler_name": "Janssen Products LP",
      "brand_name": "Symtuza",
      "active_ingredients": [
        {
          "name": "DARUNAVIR",
          "strength": "800 mg/1"
        },
        {
          "name": "COBICISTAT",
          "strength": "150 mg/1"
        },
        {
          "name": "EMTRICITABINE",
          "strength": "200 mg/1"
        },
        {
          "name": "TENOFOVIR ALAFENAMIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "59676-800-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (59676-800-30)",
          "marketing_start_date": "20180717",
          "sample": false
        },
        {
          "package_ndc": "59676-800-99",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (59676-800-99)",
          "marketing_start_date": "20180717",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Janssen Products LP"
        ],
        "rxcui": [
          "2049671",
          "2049677"
        ],
        "spl_set_id": [
          "85a17d00-6b7c-41ea-a6b3-5ad924820dab"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0359676800309"
        ],
        "nui": [
          "N0000000246",
          "N0000175889",
          "N0000190114",
          "N0000182137",
          "N0000191001",
          "N0000185503",
          "N0000190107",
          "N0000190108",
          "N0000190113",
          "N0000191423",
          "N0000175462",
          "M0015066",
          "N0000009947"
        ],
        "pharm_class_moa": [
          "HIV Protease Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Protease Inhibitor [EPC]",
          "Cytochrome P450 3A Inhibitor [EPC]",
          "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_cs": [
          "Nucleosides [CS]"
        ],
        "unii": [
          "YO603Y8113",
          "LW2E03M5PG",
          "G70B4ETF4S",
          "EL9943AG5J"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "a8468da1-a6e7-4a14-a108-23915ccaeee8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180717",
      "product_id": "59676-800_a8468da1-a6e7-4a14-a108-23915ccaeee8",
      "application_number": "NDA210455",
      "brand_name_base": "Symtuza",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitor [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "HIV Protease Inhibitors [MoA]",
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleosides [CS]",
        "Nucleosides [CS]",
        "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Protease Inhibitor [EPC]"
      ]
    }
  ]
}